BIOMAT Database Logo BIOMAT Database Logo

Late antibody-mediated rejection by de novo donor HLA-DP-specific antibody after renal transplantation: a case report. 2014

Pietro E Cippà, and Ariana Gaspert, and Christoph Etter, and Zehra Guenduez, and Sylvie Ferrari-Lacraz, and Barbara Rüsi, and Thomas Fehr
Division of Nephrology, University Hospital Zurich, Switzerland.

The role of donor HLA-DP-specific antibodies after renal transplantation is controversial, and only preformed HLA-DP-specific antibodies have been shown to mediate rejection. Here we present a case of late humoral rejection mediated by de novo donor HLA-DP-specific antibodies in a non-sensitized recipient. This unique case demonstrates the pathogenic role of de novo anti-DP antibodies and suggests that HLA-DP matching might be relevant for renal transplantation.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007678 Kidney Glomerulus A cluster of convoluted capillaries beginning at each nephric tubule in the kidney and held together by connective tissue. Glomerulus, Kidney
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006682 HLA-DP Antigens A group of the D-related HLA antigens (human) found to differ from the DR antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprising alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases. HLA-PL Antigens,HLA-SB Antigens,HLA-DP,HLA-PL,HLA-SB,Antigens, HLA-DP,Antigens, HLA-PL,Antigens, HLA-SB,HLA DP Antigens,HLA PL Antigens,HLA SB Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000920 Antibody-Dependent Cell Cytotoxicity The phenomenon of antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IMMUNOGLOBULIN G whose Fc portion is intact. The effector cell is a "killer" cell possessing Fc receptors. It may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent. ADCC,Cytotoxicity, Antibody-Dependent Cell,Cell Cytoxicity, Antibody-Dependent,Antibody Dependent Cell Cytotoxicity,Antibody-Dependent Cell Cytotoxicities,Antibody-Dependent Cell Cytoxicities,Antibody-Dependent Cell Cytoxicity,Cell Cytotoxicities, Antibody-Dependent,Cell Cytotoxicity, Antibody-Dependent,Cell Cytoxicities, Antibody-Dependent,Cell Cytoxicity, Antibody Dependent,Cytotoxicities, Antibody-Dependent Cell,Cytotoxicity, Antibody Dependent Cell,Cytoxicities, Antibody-Dependent Cell,Cytoxicity, Antibody-Dependent Cell
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies

Related Publications

Pietro E Cippà, and Ariana Gaspert, and Christoph Etter, and Zehra Guenduez, and Sylvie Ferrari-Lacraz, and Barbara Rüsi, and Thomas Fehr
Successful Treatment of Antibody-Mediated Rejection by De Novo Donor Specific Antibody After Primary Renal Transplantation in a Recipient From a Cadaveric Donor: A Case Report.
January 2020, Transplantation proceedings,
Pietro E Cippà, and Ariana Gaspert, and Christoph Etter, and Zehra Guenduez, and Sylvie Ferrari-Lacraz, and Barbara Rüsi, and Thomas Fehr
Antibody-mediated rejection owing to donor-specific HLA-DQA1 antibodies after renal transplantation: A case report.
August 2022, Transplant immunology,
Pietro E Cippà, and Ariana Gaspert, and Christoph Etter, and Zehra Guenduez, and Sylvie Ferrari-Lacraz, and Barbara Rüsi, and Thomas Fehr
Chronic Active Antibody-Mediated Rejection With Donor-Specific Anti-HLA-DP Antibodies Following Living Donor Kidney Transplantation: A Case Report.
January 2020, Transplantation proceedings,
Pietro E Cippà, and Ariana Gaspert, and Christoph Etter, and Zehra Guenduez, and Sylvie Ferrari-Lacraz, and Barbara Rüsi, and Thomas Fehr
Preformed donor HLA-DP-specific antibodies mediate acute and chronic antibody-mediated rejection following renal transplantation.
October 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
Pietro E Cippà, and Ariana Gaspert, and Christoph Etter, and Zehra Guenduez, and Sylvie Ferrari-Lacraz, and Barbara Rüsi, and Thomas Fehr
Late antibody-mediated rejection after heart transplantation following the development of de novo donor-specific human leukocyte antigen antibody.
March 2012, Transplantation,
Pietro E Cippà, and Ariana Gaspert, and Christoph Etter, and Zehra Guenduez, and Sylvie Ferrari-Lacraz, and Barbara Rüsi, and Thomas Fehr
Acute Antibody-Mediated Rejection by De Novo Anti-HLA-DPβ and -DPα Antibodies After Kidney Transplantation: A Case Report.
October 2018, Transplantation proceedings,
Pietro E Cippà, and Ariana Gaspert, and Christoph Etter, and Zehra Guenduez, and Sylvie Ferrari-Lacraz, and Barbara Rüsi, and Thomas Fehr
Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection.
December 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
Pietro E Cippà, and Ariana Gaspert, and Christoph Etter, and Zehra Guenduez, and Sylvie Ferrari-Lacraz, and Barbara Rüsi, and Thomas Fehr
Antibody-Mediated Rejection Due to Donor-Specific HLA-DQB1 and DQA1 Antibodies After Kidney Transplantation: A Case Report.
January 2020, Transplantation proceedings,
Pietro E Cippà, and Ariana Gaspert, and Christoph Etter, and Zehra Guenduez, and Sylvie Ferrari-Lacraz, and Barbara Rüsi, and Thomas Fehr
Role of de novo DQ donor-specific antibody in antibody-mediated rejection in renal transplant recipient: A case study.
January 2019, Asian journal of transfusion science,
Pietro E Cippà, and Ariana Gaspert, and Christoph Etter, and Zehra Guenduez, and Sylvie Ferrari-Lacraz, and Barbara Rüsi, and Thomas Fehr
Molecular Mismatch Predicts T Cell-Mediated Rejection and De Novo Donor-Specific Antibody Formation After Living Donor Liver Transplantation.
November 2021, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
Copied contents to your clipboard!